Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach

Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B SelectiveN-Methyl-<scp>d</scp>-Aspartate Receptor Antagonist Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists Enantiomeric Propanolamines as selectiveN-Methyl-<scp>d</scp>-aspartate 2B Receptor Antagonists Identification and in silicon binding study of a novel NR2B selective NMDAR antagonist Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists 2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity Structure−Activity Relationship of N-(Phenylalkyl)cinnamides as Novel NR2B Subtype-Selective NMDA Receptor Antagonists